Limonene

柠檬烯

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLimonene
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsFatty LiverCholecystitisCholelithiasis +[6
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active IndicationsFatty LiverCholecystitisCholelithiasis
Inactive IndicationsSubmandibular Gland NeoplasmsParotid NeoplasmsBreast Neoplasms

Other Information

ATC CodeA05